Access to efficient drugs to treat diseases that affect Canadians is among the highest priorities of our society. The development of new medicinal agents depends on the access to small molecules capable of interacting with biological targets associated with those diseases. These small molecules are typically identified by screening large collections of synthetic compounds. Paraza […]
Read More